GIP and cancer: Although both tests achieved similar blood glucose concentrations, the OGTT test suggests that hormones derived from the gut may play a role in this effect [7,11], and we observed higher levels of GIP and GLP-1 in obese cancer women with lower muscle function according to the MQI adjusted for BMI and by SMMI.